DTA-H19

BIOLOGICAL2 trials

Sponsors

Hebrew University of Jerusalem, Anchiano Therapeutics Israel Ltd.

Conditions

Bladder NeoplasmsPancreatic Neoplasms

Phase 1

Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer

CompletedNCT00393809

Hebrew University of JerusalemBladder Neoplasms

Start: 2006-01-31End: 2007-12-31Updated: 2008-01-07

Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer

CompletedNCT00711997

Anchiano Therapeutics Israel Ltd.Pancreatic Neoplasms

Start: 2009-08-31End: 2010-12-31Updated: 2019-03-20